Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 21 July 2023 31 July 2024 31 July 2024 15019112 Dr Matthew Kelleher iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15019112 2023-07-20 15019112 2024-07-31 15019112 2023-07-21 2024-07-31 15019112 frs-core:CurrentFinancialInstruments 2024-07-31 15019112 frs-bus:PrivateLimitedCompanyLtd 2023-07-21 2024-07-31 15019112 frs-bus:FilletedAccounts 2023-07-21 2024-07-31 15019112 frs-bus:Micro-entities 2023-07-21 2024-07-31 15019112 frs-bus:AuditExempt-NoAccountantsReport 2023-07-21 2024-07-31 15019112 frs-bus:Director1 2023-07-21 2024-07-31
Registered number: 15019112
Dr Kelleher Ltd
Unaudited Financial Statements
For the Period 21 July 2023 to 31 July 2024
Llama Accounting Ltd
Balance Sheet
Registered number: 15019112
31 July 2024
£
Fixed assets 3,711
Current assets 4,597
Creditors: Amounts Falling Due Within One Year (6,158 )
NET CURRENT LIABILITIES (1,561 )
TOTAL ASSETS LESS CURRENT LIABILITIES 2,150
Accruals and deferred income (480 )
NET ASSETS 1,670
CAPITAL AND RESERVES 1,670

Notes

1. General Information
Dr Kelleher Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15019112 . The registered office is 128 City Road, London, EC1V 2NX.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Matthew Kelleher
Director
18/09/2024